ReviewGerms2021
The challenges to a successful COVID-19 vaccination programme in Africa.
Review in Germs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.
- Community readiness and acceptance for the implementation of the malaria vaccine among caretakers of at-risk children in sub-Saharan Africa: a systematic review and meta-analysis.Malaria journal · 2025Pooled it
- COVID-19 vaccine acceptance among health care professionals in Ethiopia: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2023Pooled it
- Safety, Tolerability, and Immunogenicity of the TANCoV-1.3.20 SARS-CoV-2 Vaccine Among Healthy Participants in Tanzania: Protocol for a Multisite, Phase 1/2a, Double-Blinded Randomized Controlled Trial.JMIR research protocols · 2026Article
- In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein.Scientific reports · 2025Article
- Left behind no more: ensuring equitable vaccine access to curb mpox in Africa.International health · 2025Article
- Bridging the vaccine divide.Nature medicine · 2025Article
- The role of mRNA vaccines in infectious diseases: a new era of immunization.Tropical diseases, travel medicine and vaccines · 2025Review
- The COVID-19 Vaccination Rollout in Tanzania: The Role of Coordination in Its Success.Vaccines · 2025Article
- Assessing the Impact of Haulage Drivers in Uganda's COVID-19 Delta Wave.Journal of epidemiology and global health · 2025Article
- Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus.Science advances · 2025Article
- Maintenance of service delivery during medical countermeasures deployment: The association between the COVID-19 vaccine rollout and continuity of routine childhood immunization services in Uganda.PLOS global public health · 2025Article
- Determinants of COVID-19 vaccine uptake among persons with disabilities in three selected districts of Zambia.PLOS global public health · 2025Article
- Lessons learnt in the response to COVID-19 in Mozambique: enabling readiness for the next pandemic.Frontiers in health services · 2025Article
- Factors shaping Covid-19 vaccine acceptability among young people in South Africa and Nigeria: An exploratory qualitative study.PLOS global public health · 2025Article
- Exploring perceptions and attitudes towards vaccines in a remote western DRC health zone.Vaccine: X · 2025Article
- Factors associated with COVID-19 vaccine uptake and hesitancy among women of reproductive age in Mozambique.Frontiers in public health · 2025Article
- Lessons and challenges of practice of traditional medicines as an alternative for COVID-19 vaccine in Tanzania.Journal of public health in Africa · 2025Article
- Variations in COVID-19 vaccine hesitancy over time: a serial cross-sectional study in five West African countries.BMJ open · 2024Observational
- Human papilloma virus vaccination in the resource-limited settings of sub-Saharan Africa: Challenges and recommendations.Vaccine: X · 2024Review
- A Scoping Review of Factors Affecting COVID-19 Vaccination Uptake and Deployment in Global Healthcare Systems.Vaccines · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 vaccination campaign is an ongoing worldwide effort to vaccinate large numbers of people against COVID-19 in order to ensure protection from the disease, control the rate of infection, reduce severe outcomes, and get back to normal life. Most African countries had a delay in the initiation of their COVID-19 vaccine national rollout compared to other regions in the world, and the goal of the immunization exercise in the continent is to vaccinate over 60% of the African population to attain herd immunity. Over the years, vaccination programmes are usually faced with challenges in Africa because of numerous factors. So far, some of the major challenges threatening the success of the COVID-19 vaccination rollout in most African countries includes the slow onset of the vaccination exercise, limited funds, concerns around vaccine safety and uncertainties, storage requirements and regulatory hurdles for vaccines, limited shelf life of COVID-19 vaccines, inability to access vulnerable communities in a timely fashion, problems around the use of different vaccines, and wars and conflicts. The solutions and other imperative recommendations to these challenges were provided so as to optimize the vaccination programme and to achieve an appreciable success in the COVID-19 vaccination programme on the continent. In conclusion, a holistic and timely planning, fast execution of plans, rigorous community involvement, and a robust multi-sectoral partnership will ensure a successful COVID-19 vaccination campaign in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.